Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Diabetic Foot Ulcers, Vascular Problems Predict DeathLower limb vascular complications and foot ulcers are significant predictors of mortality in patients with diabetes, a new study shows, so physicians should be on the lookout for such symptoms.
Medscape Medical News, July 13, 2016
Seize Technology to Strengthen Doctor-Patient InteractionMost people with type 2 diabetes are managed in primary care, but many of these patients have multiple concerns that cannot be addressed in a single visit and may require innovative tactics for care.
Medscape Medical News, June 27, 2016
Antenatal Lifestyle Interventions Improve Pregnancy OutcomesPregnant women and their babies have less gestational diabetes and better outcomes with early interventions to improve diet and exercise, but one size does not fit all in pregnancy weight gain.
No CV Benefit With Lixisenatide in ELIXA, but Results Reassure The first cardiovascular outcomes study with a GLP-1 agonist for type 2 diabetes shows no signal of cardiovascular harm with
lixisenatide, reassuring doctors this is a safe, if expensive, way to lower glucose.
Medscape Medical News, June 8, 2015
Hope Ahead? Varying Approaches Progress Artificial Pancreas A new study suggests glucagon may add benefit, but whether that outweighs its cost and complexity remains unclear. Other studies
show progress with both single- and dual-hormone systems.
Medscape Medical News, June 15, 2015
Low Vitamin D Levels Common in Painful Diabetic Neuropathy Results from a study of 45 people suggest that low vitamin D levels may play a role in the pathogenesis of painful diabetic
peripheral neuropathy and that vitamin D supplementation could lead to improvement.
Per-Henrik Groop, MD Helsinki University Central Hospital, Finland Presentation: Excess CVD Morbidity in Type 1 Diabetes According to Nephropathy and Kidney Function Date: June 11, 2016 Presentation: Effects of Linagliptin on Glycemic Control and Albuminuria in Type 2 Diabetes-The MARLINA-T2D Trial Date: June 12, 2016 Presentation: Metabolic Subtypes of Type 1 Diabetes, Medication Costs, and Progression of Diabetic Kidney Disease during 14 Years of Follow-Up Date: June 12, 2016 Presentation: Pedigree-based Analysis of Diabetic Nephropathy in T1D Patients Date: June 12, 2016
Vivian Fonseca, MD Tulane University, New Orleans, Louisiana Presentation: The Effect of Metformin Exposure on Neurodegenerative Disease among Elder Adult Veterans with Diabetes Mellitus Date: June 11, 2016 Presentation: Linagliptin Modulates Intra-islet GLP-1 vs. Glucagon Secretion and Production Date: June 12, 2016 Presentation: Life-Course Interaction between Fasting Blood Glucose and Body Mass Index Affects Mid-adulthood Physical Performance Date: June 12, 2016 Presentation: Birth Weight and Cardiometabolic Risk in Children: The National Health and Nutrition Examination Survey (NHANES), 1999-2014 Date: June 12, 2016 Presentation: Metformin Exposure Is Associated with Diabetic Neuropathy Date: June 13, 2016
Anne Peters, MD University of Southern California at Los Angeles Presentation: HbA1c Knowledge in Adults with Type 1 Diabetes: Does Patient Accuracy Matter? Date: June 11, 2016 Presentation: Impact of Intensive Lifestyle Intervention on the Compression of Lifetime Disability: The Look AHEAD Trial Date: June 11, 2016 Presentation: Improved Treatment Satisfaction in People with Type 1 Diabetes Mellitus (T1DM) Treated with Canagliflozin (CANA) Date: June 12, 2016 Presentation: Canagliflozin (CANA) Improves Glycemic Control and Reduces Glycemic Variability in Patients with Type 1 Diabetes Mellitus
(T1DM) Inadequately Controlled with Insulin Date: June 13, 2016
Arya Sharma, MD, PhD University of Alberta; Royal Alexandra Hospital, Weight Wise Clinic, Edmonton, Alberta Presentation: Drug Interventions Date: June 12, 2016